During acute rejection, coronary vascular reserve is severely impaired in human orthotopic heart transplants. To evaluate the effects of rejection therapy on coronary vascular reserve, the ratio of peak-to-resting coronary flow velocity was assessed with a coronary Doppler catheter and a maximally vasodilating dose of intracoronary papaverine (12 mg) in nine allograft recipients without rejection (group 1) and in six recipients before and after treatment of an acute episode of rejection (group 2). All the patients had normal epicardial coronary arteries and were free of left ventricular hypertrophy. In group 2 during rejection, the coronary vascular reserve was significantly lower than in group 1, in which all the patients had a peak-to-resting coronary flow velocity ratio greater than 4 (2.3 0.5 vs. 5.4 ±0.8, respectively,p <0.001). In group 2 after treatment of rejection, the peak-to-resting coronary flow velocity ratio was similar to that of group 1 (4.7+±0.8). Heart rate, left ventricular volumes and pressures, hemoglobin concentration, and arterial oxygen pressure were similar in the two groups. This study provides evidence that alterations of coronary vascular reserve because of acute rejection were reversible after treatment of the rejection episode. (Circulation 1990;81:1312-1318 reported to be normal in the absence of rejection. On the other hand, during allograft rejection, coronary flow increase after intravenous dipyridamole was severely impaired.45 Whether this impairment of coronary vasodilator capacity observed during heart rejection is reversible with rejection therapy might be of clinical importance. The objective of the present study was, therefore, to assess the effects of rejection therapy on coronary vasodilator reserve in cardiac allograft recipients with acute rejection. Coronary vasodilator capacity was estimated with coronary Doppler catheter and a maximally vasodilating dose of intracoronary papaverine7,8 in allograft recipients before and after treatment of the episode of rejection. Results were compared with those of recipients without heart rejection.
During acute rejection, coronary vascular reserve is severely impaired in human orthotopic heart transplants. To evaluate the effects of rejection therapy on coronary vascular reserve, the ratio of peak-to-resting coronary flow velocity was assessed with a coronary Doppler catheter and a maximally vasodilating dose of intracoronary papaverine (12 mg) in nine allograft recipients without rejection (group 1) and in six recipients before and after treatment of an acute episode of rejection (group 2). All the patients had normal epicardial coronary arteries and were free of left ventricular hypertrophy. In group 2 during rejection, the coronary vascular reserve was significantly lower than in group 1, in which all the patients had a peak-to-resting coronary flow velocity ratio greater than 4 (2.3 0.5 vs. 5.4 ±0.8, respectively,p <0.001). In group 2 after treatment of rejection, the peak-to-resting coronary flow velocity ratio was similar to that of group 1 (4.7+±0.8). Heart rate, left ventricular volumes and pressures, hemoglobin concentration, and arterial oxygen pressure were similar in the two groups. This study provides evidence that alterations of coronary vascular reserve because of acute rejection were reversible after treatment of the rejection episode. (Circulation 1990; 81:1312 -1318 H uman cardiac transplantation is frequently proposed as the ultimate treatment of endstage heart failure. Together with infectious complications and early graft failure, acute rejection is a major impediment of survival. Although the early phase of acute rejection of cardiac allografts is accompanied by evidence of vascular injury,12 during the past decade, most of the studies dedicated to human orthotopic heart transplantation have focused on myocardial mechanical performance and accelerated atherosclerosis of the major coronary arteries. Attention has been recently directed to the coronary vascular reactivity and the coronary vasodilator reserve of the human transplanted heart. Dipyridamole-induced vasodilation3-5 and coronary vasodilator reserve assessed by Doppler velocity measurement after intracoronary papaverine6 have been reported to be normal in the absence of rejection. On the other hand, during allograft rejection, coronary flow increase after intravenous dipyridamole was severely impaired.45 Whether this impairment of coronary vasodilator capacity observed during heart rejection is reversible with rejection therapy might be of clinical importance.
The objective of the present study was, therefore, to assess the effects of rejection therapy on coronary vasodilator reserve in cardiac allograft recipients with acute rejection. Coronary vasodilator capacity was estimated with coronary Doppler catheter and a maximally vasodilating dose of intracoronary papaverine7,8 in allograft recipients before and after treatment of the episode of rejection. Results were compared with those of recipients without heart rejection.
Methods

Patient Selection and Posttransplant Care
Because left ventricular hypertrophy per se is a factor of reduction of coronary flow reserve,9 the study group comprised 15 selected cardiac allograft recipients without left ventricular hypertrophy at two-dimensional and M-mode echocardiography performed the day before right ventricular endomyocardial biopsy (diastolic septal or posterior wall thickness to Billingham criteria.10 method). Azathioprine (1.0-1.5 mg/kg/day) was administered to five of nine patients of group 1 and four of six patients of group 2. Nicardipine was prescribed to two patients of group 1 and to one patient of group 2; one patient of group 2 received nifedipine.
In Hopital Henri Mondor, all patients with rejection, including patients with mild rejection before the sixth month after surgery and from the sixth to the 12th month after transplantation, and patients with mild rejection and previous episodes of rejection were treated with prednisolone (1 mg/kg during 6 days) until complete resolution of the rejection episode was obtained. During this period, biopsies were performed twice a week and read by two independent observers who did not know that the patients were included in the study. Thereafter, biopsies were realized on alternate weeks during 3 months. The catheterization procedure was repeated at least 1 month after complete resolution of the rejection crisis, that is, the day after a negative endomyocardial biopsy. Catheterization Protocol All patients were in the fasting state for at least 12 hours before the procedure. Calcium blockers were discontinued 24 hours before the investigation. No premedication was administered, and 1% lidocaine was used for local anesthesia.
Patients underwent pulmonary artery catheterization with a thermodilution catheter (Edwards Laboratories). The Seldinger approach from a right femoral Coronary arteriograms of each coronary artery were obtained in multiple projections after maximal epicardial coronary artery vasodilation was obtained by intracoronary injection of 1.5 mg of isosorbide dinitrate.7 Arteriograms were obtained by digital subtraction at a rate of 6 frames/sec on a 512-pixel matrix.
To evaluate coronary vasodilator reserve, the following procedure was achieved according to were continuously recorded in basal condition and after the injection of 12 mg of papaverine hydrochloride through the guiding catheter into the left coronary artery (8 mg/papaverine/ml 0.9% saline; 1.5 ml of the solution was introduced into the guiding catheter and flushed with 0.9% saline). The guiding catheter was withdrawn from the coronary ostium after injection of papaverine. Coronary flow reserve was calculated as the peak-to-resting coronary flow velocity ratio (average of two measures; the second one was performed after return to basal value of coronary flow velocity).
Statistical Analysis
Mean values±SD were calculated for each variable. Data from group 1 and group 2 patients were compared by an unpaired t test. In group 2, data before and after treatment of rejection were compared by a paired t test. Significance was determined forp values less than 0.05.
Results
Angiographic Data
Left ventricular angiography evidenced similar values of left ventricular end-diastolic and end-systolic volumes, and ejection fraction in group 1 and in group 2 patients during rejection (Table 3) . In group 2 patients, results were not significantly modified after rejection therapy (Table 3) . Coronary arteriography showed normal epicardial coronary arteries in all patients. (Table 3) . In group 2, all the hemodynamic parameters were similar before and after rejection therapy (Table 3) . Hemoglobin concentration was higher than 10 g/100 ml blood in all patients without any statistical difference between the groups. Arterial oxygen pressure was similar in the two groups (Table 3 ). The extent of the decline of mean aortic pressure after intracoronary injection of papaverine was not different between group 1 and group 2, and in group 2 before and after treatment of rejection crisis (8±3% in group 1, 9±3% in group 2 during rejection, and 10±4% after rejection therapy).
Coronary Vasodilator Reserve
The coronary vasodilator reserve was significantly lower in patients with rejection as compared with patients without rejection ( Figure 1 ). All patients without rejection had a peak-to-resting coronary blood flow velocity ratio greater than 4.0, which was higher than the lower limit of normality of 3.5 determined by Wilson et al.12 There was no correlation between the flow velocity ratio and the number of previous episodes of rejection. Conversely, patients with rejection had a peak-to-resting coronary blood flow velocity ratio smaller than 3.0. After rejection therapy, the ratio was dramatically increased, and all the group 2 patients had a coronary reserve similar to that of group 1 patients (Figures 1  and 2 ischemia when the myocardial metabolic demand increases during acute rejection crisis, whether these alterations of coronary vasodilator capacity are reversible with rejection therapy is a question of importance from both a pathophysiological and clinical standpoint.
The major finding of the present study was that the impairment of coronary vasodilator reserve in orthotopically transplanted patients with mild-tomoderate histological signs of rejection was reversible with rejection therapy. Additionally, although the number of group 2 patients was small, it seems that the level of coronary flow reserve during rejection did not depend on the grade of rejection and did not allow prediction of the peak-to-resting flow velocity ratio after therapy. Among the group 2 patients, patients 10 and 12 with mild rejection had a ratio lower than 1.8, and patient 15 with moderate rejection had a ratio of 2.9. After treatment, their ratios were 4. lean blockers used in all the groups were short-acting drugs, and although the small number of patients receiving these agents in each group did not allow statistical analysis, it is unlikely that our results could have been affected by calcium blockers. Cyclosporine, which could alter flow in allograft transplants,3233 cannot explain differences between the two groups of patients receiving similar immunosuppressive treatment. Fifth, accelerated coronary atherosclerosis in patients treated by cyclosporine and prednisolone34'35 could be a potent mechanism of reduction of coronary reserve. This mechanism can be disregarded for all the group 2 patients who had normal epicardial coronary arteries on coronary arteriograms. Additionally, all the group 2 patients were investigated within the first year after surgery (Table  2) , and previous studies demonstrated that at 1 year, the prevalence of coronary artery disease at 19% and stenoses at 50% was uncommon.3435 Most importantly, the normalization of coronary reserve after treatment of rejection does not support fixed lesions of the coronary vasculature and suggests that even if distal atherosclerosis was present, it was not severe enough to reduce coronary reserve.
This study provides evidence that in patients with mild-to-moderate histological signs of rejection, alterations of coronary vascular reserve were reversible when immunosuppressive therapy is provided. This is in accordance with the fact that when rejection therapy is promptly administered, minor left ventricular functional and histological abnormalities because of mild-to-moderate rejection could be reversed.21'36 Such a response of coronary circulation to vasodilator drugs during acute rejection might be clinically important in the management of rejection crisis and might be interesting for future research dedicated to noninvasive monitoring of patients with heart transplantation. Thus, myocardial kinetics of Tc-MIBI,37 measurement of myocardial blood flow by positron-emission tomography38 or by ultrafast computed tomography39 could eventually serve as a means of rejection diagnosis such that coronary flow reserve is impaired even in patients with mild rejection. Consequences of more severe rejection or of repetitive rejection episodes on the coronary microvasculature are unknown. Scar fibrosis could result in extravascular compression of coronary microvessels, reduction of the number of functional vessels, or both, and could induce a gradual decline of coronary vascular reserve, which is still to be evaluated by further studies.
